Comparison of early and late changes in immunoglobulins and acute phase reactants after laparoscopic adjustable gastric banding in patients with morbid obesity

Obesity Surgery

Volumn 20, Issue 5, 2010, Pages 610-615

  Sakçak, Ibrahim ^a,c,d   Avşar, Mehmet Fatih ^a   Hamamci, Enver Okan ^a   Bostanoǧlu, Settar ^a   Sonişik, Muhittin ^a   Bostanoǧlu, Akin ^a   Erdem, Nihal Zekiye ^a   Coşgun, Erdal ^b  

^a Numune Teaching and Research Hospital ^*  (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Numune Hospital   (Turkey)

^d Cukurambar Mahallesi   (Turkey)

Author keywords

CRP; Gastric banding; Immunoglobulin; Inflammation; Obesity

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GASTRIC BANDING; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NEUTROPHIL COUNT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTE COUNT; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

BLOOD PRESSURE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COMPLEMENT C3; COMPLEMENT C4; FEMALE; GASTROPLASTY; HUMANS; IMMUNOGLOBULINS; LAPAROSCOPY; LEUKOCYTE COUNT; MALE; OBESITY, MORBID; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; WEIGHT LOSS;

EID: 77953287294     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-009-0061-y     Document Type: Article

References (32)

1. Lew EA, Garfinkel L. Variations in mortality by weight among 750, 000 men and women. J Chronic Dis. 1979; 32:563-576 (Pubitemid 9256615)
2. National Institutes of Health. National Institutes of Health Consensus Development panel on the Health Implications of Obesity. National Institutes of Health Consensus development conference statement. Ann Intern Med. 1985; 103:1072-1077
3. Krishnan EC, Trost L, Aarons S, et al. Study of function and maturation of monocytes in morbidly obese individuals. J Surg Res. 1982; 33:89-97. (Pubitemid 12039065)
4. Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004; 14:589-600. (Pubitemid 38716577)
5. Brownell KD, Greenwood MR, Stellar E, et al. The effects of repeated cycles of weight loss and regain in rats. Physiol Behav. 1986; 38:459-464 (Pubitemid 17191211)
6. Holt RI. International Diabetes Federation re-defines the metabolic syndrome. Diabetes Obes Metab. 2005; 7:618-620
7. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282:2131-2135
8. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999; 22:1971-1977 (Pubitemid 30433974)
9. Schuchert VD, Billiar TR. Inflammation. In: Greenfield LJ, editor. Surgery Scientific principals and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 134-178
10. Mohamed-Ali V, Pinkney JH, Coppack SW Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998; 22:1145-1158 (Pubitemid 28548534)
11. Weinhold B, Rüther U. Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J. 1997; 327:425-429 (Pubitemid 27477818)
12. Van Harmelen V, Ariapart P, Hoffstedt J, et al. Increased adipose angiotensinogen gene expression in human obesity. Obes Res. 2000; 8:337-341
13. Korenkov M, Shah S, Sauerland S, et al. Impact of laparoscopic adjustable gastric banding on obesity co-morbidities in the medium- and long-term. Obes Surg. 2007; 17:679-683 (Pubitemid 46945429)
14. Fanari P, Somazzi R, Nasrawi F, et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes Relat Metab Disord. 1993; 17:487-494 (Pubitemid 23269126)
15. Freedman DS, Joesoef MR, Barboriak JJ, et al. Correlates of leukocyte counts in men. Ann Epidemiol. 1996; 6:74-82.
16. Paolo F, Somazzi R, Nasrawi F, et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes. 1993; 17:487-494
17. Marks HH. Influence of obesity on morbidity and mortality. Bull NY Acad Med. 1960; 36:296-312.
18. Tracey VV, De NC, Harper JR. Obesity and respiratory infection in infants and young children. Br Med J. 1971; 1:16-18
19. Hanusch-Enserer U, Cauza E, Spak. M, et al. Acute-phase response and immunological markers in morbid obese patientsand patients following adjustable gastric banding. Int J Obes Relat Metab Disord. 2003; 27:355-361
20. Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord. 2002; 26:659-662
21. Vázquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005; 90:316-322
22. Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003; 23:1042-1047
23. Marckrnann P, Toubro S, Astrup A. Sustained improvement in blood, lipids, coagulation, and fibrinolysis after major weight loss in obese subjects. Eur J Clin Nutr. 1998; 52:329-333
24. Primrose JN, Davies JA, Prentice CR, et al. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost. 1992; 68:396-399
25. Rowan BO, Kuhl DA, Lee MD, et al. Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin. Obes Surg. 2008; 18:162-166
26. Ditschuneit HH, Flechtner-Mors M, Adler G. Fibrinogen in obesity before and after weight reduction. Obes Res. 1995; 3:43-48
27. Haffner SM, Mykkänen L, Festa A, et al. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000; 101:975-980
28. Stallone DD, Stunkard AJ, Zweiman B, et al. Decline in delayedtype hypersensitivity response in obese women following weight reduction. Clin Diagn Lab Immunol. 1994; 1:202-205 (Pubitemid 2057619)
29. Nieman DC, Nehlsen-Cannarella SI, Henson DA, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996; 20:353-360
30. Solá E, Jover A, López-Ruiz A, et al. Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss. Obes Surg. 2009; 19:571-576
31. Vilarrasa N, Vendrell J, Sánchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf). 2007; 67:679-686 (Pubitemid 47628468)
32. Whitson BA, D'Cunha J, Hoang CD, et al. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells. Surg Obes Relat Dis. 2009; 5:181-193